Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Cerner Corp Stock Research

CERN

Market Closed
Watchlist

CERN RSI Chart

CERN Valuation

CERN Price/Sales (Trailing)

CERN Profitability

CERN Fundamentals

CERN Revenue

CERN Earnings

Price Action

CERN Financial Health

CERN Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for CERN

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-06-08
WISE R HALSEY
back to issuer
-302,860
95.00
-3,188
-
2022-06-08
Granger Elder
back to issuer
-513,285
95.00
-5,403
-
2022-06-08
Battaglioli Michael R.
back to issuer
-324,140
95.00
-3,412
svp & chief accounting officer
2022-06-08
ZOLLARS WILLIAM D
back to issuer
-349,600
95.00
-3,680
-
2022-06-07
Labat Jerome
sold
-2,081,360
95.00
-21,909
evp & chief technology officer
2022-06-07
Dalton Travis
sold
-43,130
95.00
-454
evp & chief client & serv. off
2022-06-07
Labat Jerome
sold
-3,515
95.00
-37.00
evp & chief technology officer
2022-06-07
Dalton Travis
sold
-51,205
95.00
-539
evp & chief client & serv. off
2022-06-07
Daniels Mitchell E
sold
-3,558,700
95.00
-37,460
-
2022-06-07
Erceg Mark J
sold
-4,170,980
95.00
-43,905
exec. vp & cfo

1–10 of 50

Which funds bought or sold CERN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-08-11
HUNTINGTON NATIONAL BANK
unchanged
-
-
95.00
-%
2022-08-15
Frontier Wealth Management LLC
sold off
-100
-757,000
-
-%
2022-08-11
ADVISOR PARTNERS LLC
sold off
-100
-935,000
-
-%
2022-08-05
Fieldpoint Private Securities, LLC
sold off
-100
-163,000
-
-%
2022-07-28
Private Capital Group, LLC
sold off
-100
-31,000
-
-%
2022-07-20
IBM Retirement Fund
sold off
-100
-441,000
-
-%
2022-05-23
SPRING CREEK CAPITAL LLC
new
-
65,492,000
65,492,000
2.59%
2022-05-16
Barrett Asset Management, LLC
reduced
-2.49
-8,000
406,000
0.02%
2022-05-16
Tibra Equities Europe Ltd
new
-
21,185,000
21,185,000
23.44%
2022-05-16
Amalgamated Financial Corp.
new
-
7,659,000
7,659,000
0.06%

1–10 of 44

Latest Funds Activity

Are funds buying CERN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CERN
No. of Funds

Schedule 13G FIlings of Cerner

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2022
vanguard group inc
10.81%
31,586,238
SC 13G/A
Feb 07, 2022
blackrock inc.
8.3%
24,425,920
SC 13G/A
Mar 10, 2021
bank of new york mellon corp
3.18%
9,742,229
SC 13G/A
Feb 10, 2021
vanguard group inc
10.65%
32,645,742
SC 13G/A
Feb 01, 2021
bank of new york mellon corp
5.21%
15,965,148
SC 13G
Jan 29, 2021
blackrock inc.
8.2%
25,096,524
SC 13G/A
Feb 12, 2020
vanguard group inc
10.65%
33,451,876
SC 13G/A
Feb 05, 2020
blackrock inc.
7.5%
23,516,312
SC 13G/A

Peers (Alternatives to Cerner)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
467.4B
348.5B
2.58% -0.25%
22.14
1.34
13.69% 15.63%
32.5B
2.2B
5.64% 23.45%
60.21
14.57
11.56% 37.20%
MID-CAP
3.1B
2.5B
-17.96% -29.13%
-0.76
1.21
13.30% 59.30%
2.0B
1.2B
-21.78% -48.72%
-87.82
1.65
-1.77% -138.27%
SMALL-CAP
1.6B
678.1M
29.11% 32.94%
675.84
2.35
12.34% 2970.73%
1.4B
-
-3.24% -14.12%
22.47
1.63
- -
996.5M
319.4M
-33.90% -26.22%
-6.54
3.12
30.27% 15.64%
876.4M
2.4B
-3.35% -15.07%
7.05
0.36
-5.09% -42.39%
830.9M
55.7M
-8.25% -13.52%
79.99
14.92
7.05% -12.17%
662.2M
274.0M
1.98% 1.31%
51.45
2.42
5.60% 81.56%
572.2M
284.6M
-11.69% -0.49%
-3.88
2.01
7.33% -1.68%
226.3M
336.9M
-7.81% -43.13%
45.96
0.67
10.57% -74.53%

Cerner News

Investing.com
Oracle reasserts $65 billion revenue forecast for 2026 despite recent ....
Investing.com,
11 days ago
Investing.com Nigeria
英为财情 Investing.com
Investing.com Nigeria
Investing.com España
Investing.com 香港
Investing.com France

Returns for CERN

Financials for Cerner

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q12017Q42017Q32017Q22017Q1
Revenue0.7%5,8075,7655,7085,6085,4825,5065,5535,6145,7145,6935,6165,5275,4635,3665,3145,2505,1755,1425,0864,9954,919
Costs and Expenses0.2%5,0655,0575,0414,9724,7484,8124,8505,0175,1335,0925,0344,8264,6864,5924,4854,3804,2634,1824,1334,0473,979
  S&GA Expenses-0.6%518521491486464492513549564521497448393389383364359355388391391
EBITDA2.3%1,4511,4181,3771,6111,7311,6931,7081,3491,3301,3461,3171,417---------
EBITDA Margin1.6%0.25*0.25*0.24*0.29*0.32*0.31*0.31*0.24*0.23*0.24*0.23*0.26*---------
Earnings Before Taxes4.7%7326996639031,0279911,007650632655635746807801851887924967961953944
EBT Margin3.9%0.13*0.12*0.12*0.16*0.19*0.18*0.18*0.12*0.11*0.11*0.11*0.14*---------
Net Income6.1%589556522703805780793518510529506594636630835843854867680673659
Net Income Margin5.3%0.10*0.10*0.09*0.13*0.15*0.14*0.14*0.09*0.09*0.09*0.09*0.11*---------
Free Cashflow-2.8%1,4401,4821,4741,3971,2931,1531,041971878842753734---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q12017Q42017Q32017Q22017Q1
Assets-0.8%7,3747,4347,5437,7217,9087,5217,3616,8796,7366,8956,9377,2766,9996,7096,7856,5296,5126,4696,2326,0595,803
  Current Assets0.8%2,4682,4492,4402,5413,0552,6512,5252,0541,9642,0972,2132,6022,4242,3192,3872,3792,3652,3802,2322,0121,826
    Cash Equivalents20.3%710590460246998616419270285442496703503374499511413371573460378
  Inventory-1.6%28.0028.0025.0020.0030.0023.0016.0019.0023.0023.0023.0023.0024.0025.0025.0015.0014.0016.0016.0015.0019.00
  Net PPE-2.8%1,6101,6561,7181,7691,8031,8041,8681,8711,8351,8591,8661,8661,7901,7441,6971,6661,6011,6031,5871,5941,569
  Goodwill-0.1%1,1301,1311,1271,130912915907912881883845848847848848849854853852850846
Liabilities-7.7%3,4663,7543,7033,6953,5963,0392,9552,8612,8732,5772,5262,5591,8691,7801,7201,6501,6111,6841,6681,7031,690
  Current Liabilities-15.2%1,3791,6261,5511,5431,4631,1691,1021,0071,0181,0271,0021,031941963907836803790807842834
  Long Term Debt-------------439439439439439515521525533
    LT Debt, Current-100.0%-225225225225----------------
    LT Debt, Non Current0.0%1,6111,6111,6111,6111,6111,3361,3361,3381,3381,0381,0391,039-439-------
Shareholder's Equity6.2%3,9093,6803,8404,0264,3124,4834,4064,0183,8634,3174,4114,7175,1294,9285,0664,8794,9004,7854,5644,3564,113
  Retained Earnings1.9%6,8776,7526,6576,5476,5816,4766,4026,1016,0225,9355,8375,8125,7435,5775,4455,2765,1064,9394,6024,4254,245
  Additional Paid-In Capital3.5%2,8122,7172,5992,5102,3682,2892,1962,1202,0541,9051,8071,7221,5911,5601,5271,4441,4141,3801,3451,3011,255
Shares Outstanding-293-296301305-306305310-316321325-329330332-332331330
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q12017Q42017Q32017Q22017Q1
Cashflow From Operations-4.3%1,6961,7721,7671,7141,6041,4371,3621,3311,2791,3131,2821,2691,3621,4541,3961,4211,4131,3081,2971,2451,213
  Share Based Compensation-7.2%18219620118316715314213512210497.0093.0094.0095.0010296.0093.0083.0080.0079.0077.00
Cashflow From Investing23.3%-559-729-909-1,327-846-801-800-734-593-640-703-909-801-828-974-875-1,113-1,005-687-693-590
Cashflow From Financing-34.0%-1,413-1,054-809-414-48.42-461-634-1,019-890-601-576-164-462-609-484-488-269-110-469-468-532
  Dividend Payments4.4%27926725724623322122322517011457.00----------
  Buy Backs-22.8%1,1581,5001,2328574497579501,3501,9501,3211,298956556623495461261173524500550

CERN Income Statement

2022-03-31
Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues$ 1,429,801$ 1,387,778
Costs and expenses:  
Costs of revenue243,848230,656
Sales and client service612,997622,176
Software development (Includes amortization of $65,206 and $64,850, respectively)195,091192,327
General and administrative109,279112,365
Amortization of acquisition-related intangibles16,60212,196
Total costs and expenses1,177,8171,169,720
Operating earnings251,984218,058
Other income, net261,206
Earnings before income taxes252,010219,264
Income taxes(45,881)(47,012)
Net earnings$ 206,129$ 172,252
Basic earnings per share$ 0.70$ 0.57
Diluted earnings per share$ 0.70$ 0.56
Basic weighted average shares outstanding293,412304,731
Diluted weighted average shares outstanding296,336308,031

CERN Balance Sheet

2022-03-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 709,532$ 589,847
Short-term investments171,180252,622
Receivables, net1,178,0371,161,361
Inventory27,70428,159
Prepaid expenses and other381,404417,465
Total current assets2,467,8572,449,454
Property and equipment, net1,610,4961,656,171
Right-of-use assets76,47482,940
Software development costs, net1,003,8061,000,357
Goodwill1,129,5391,131,121
Intangible assets, net434,900458,482
Long-term investments456,398461,984
Other assets194,761193,649
Total assets7,374,2317,434,158
Current liabilities:  
Accounts payable359,562329,582
Current installments of long-term debt0225,000
Deferred revenue456,929531,234
Accrued payroll and tax withholdings284,145317,092
Other current liabilities278,236223,350
Total current liabilities1,378,8721,626,258
Long-term Debt1,611,3031,611,256
Deferred income taxes362,236395,177
Other liabilities113,301121,005
Total liabilities3,465,7123,753,696
Shareholders' Equity:  
Common stock, $0.01 par value, 500,000,000 shares authorized, 381,357,862 shares issued at March 31, 2022 and 380,232,975 shares issued at December 31, 20213,8143,802
Additional paid-in capital2,811,6122,717,244
Retained earnings6,877,1116,751,692
Treasury stock, 87,383,166 shares at March 31, 2022 and December 31, 2021(5,664,718)(5,664,718)
Accumulated other comprehensive loss, net(119,300)(127,558)
Total shareholders' equity3,908,5193,680,462
Total liabilities and shareholders' equity$ 7,374,231$ 7,434,158
Common stock, par value$ 0.01 
Common Stock, Shares Authorized500,000,000 
Common stock, shares issued381,357,862380,232,975
Treasury Stock, Shares87,383,166 
David T. Feinberg
25200
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. The company also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, it offers a portfolio of clinical and financial healthcare information technology solutions, as well as departmental and care coordination solutions. Further, the company provides tech-enabled services, such as implementation and training, remote hosting, application management, revenue cycle, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, and data-driven services; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri.